Cleartest Corona ford. Nasal detection of SARS-COV-2 prof.application

Cleartest Corona Anterior Nasal SARS-CoV-2 Detection for Professional Use

The Cleartest Corona Rapid Test is a reliable and fast test for the detection of SARS-CoV-2 antigens in the anterior nose.

Description

The SARS-CoV-2 Antigen Rapid Test (nasal swab) is a chromatographic immunoassay developed for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in anterior nasal swab specimens. This test is intended exclusively for professional in vitro diagnostic use and offers high accuracy and reliability. It is both BfArM-listed and PEI-evaluated with test ID AT766/21. The latest virus variants, such as XEC and KP.3.1.1, can be effectively detected with this rapid test. With a sensitivity of 97.4%, a specificity of 99.9%, and an overall accuracy of 99.0%, this test delivers rapid results within 15 minutes. The test should be stored at temperatures between 2 and 30 °C and should not be frozen.

Key Features

• Chromatographic immunoassay for the qualitative detection of SARS-CoV-2.
• Listed by BfArM and evaluated by PEI with test ID AT766/21.
• Effective detection of the latest variants, XEC and KP.3.1.1.
• Sensitivity: 97.4%
• Specificity: 99.9%
• Accuracy: 99.0%
• Results in just 15 minutes.
• Store at 2–30 °C; do not freeze.
• Available in packs of 100 or 20 tests.

Applications

• Hospitals and clinics
• Medical practices
• Testing centers
• Care facilities
• Laboratories

Summary

The Cleartest Corona Rapid Test offers a fast, reliable, and professional solution for detecting SARS-CoV-2 antigens. With its high accuracy and ability to detect the latest variants, this test is an indispensable tool in modern diagnostics.